Shane Hellmrich
Sources cited above. More about my background →
SEO for peptide brands matters more than most niches, because most peptide brands can't run paid ads at all. Google and Meta both restrict peptide advertising heavily. SEO is often the only channel left, and it has to be built compliantly from day one.
I only work with brands operating inside FDA and FTC rules. See who this isn't for below.Most peptide brands find out fast that Google Ads and Meta both reject or ban peptide-related campaigns outright. That's not a policy quirk, it's consistent across the industry.
That makes organic search the main channel most brands have left. A brand that treats SEO as a nice-to-have here is making a mistake most competitors already learned the hard way.
Answer-first product and category pages, written to what the FDA and FTC actually allow for an unapproved-drug category. Editorial link building through genuinely citation-worthy content, not paid placements or PBNs.
I check the FDA's bulk-drug-substance list before writing any claim tied to compounding legality. That list changes, and content built on last year's version can put your brand at risk.
Google and Meta both restrict peptide advertising broadly. It's consistent enough across the industry that most brands stop trying and focus on SEO instead.
No. I don't work with brands selling unapproved research chemicals alongside implied treatment claims. I work with brands operating inside FDA and FTC rules.
Yes, through editorial, citation-worthy content. No paid links, no PBNs, no outreach spam.
Tell me about your brand and where you're stuck. I'll tell you honestly if I'm a fit.
Get in touch →